Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study

Table 4 Site of infection and implicated organisms in patients who suffered from single vs repeated episodes of infection n (%)

	Single episode (n = 21)	Repeated episodes (n = 36)1	P value
Site of organism isolation			0.896
Bile	6 (28.6)	10 (27.8)
Wound	1 (4.8)	2 (5.6)
Sputum	3 (14.3)	7 (19.4)
Drains	5 (23.8)	7 (19.4)
Blood	3 (14.3)	8 (22.2)
Urine	2 (9.5)	2 (5.6)
Ascitic fluid	1 (4.8)	0 (0.0)
Oragnism isolated			0.456
Goagulase (-) Staph. aureus	3 (14.3)	1 (2.8)
Staph. aureus	0 (0.0)	1 (2.8)
MRSA	3 (14.3)	1 (2.8)
E. coli	2 (9.5)	4 (11.1)
Klebsiella species	2 (9.5)	3 (8.3)
Pseudomonas aeruginosa	4 (19.0)	3 (8.3)
Acinetobacter baumannii	4 (19.0)	12 (33.3)
Proteus	0 (0.0)	2 (5.6)
Enterobacteriaceae	1 (4.8)	1 (2.8)
Enterococci	1 (4.8)	2 (5.6)
Bacillus species	0 (0.0)	2 (5.6)
Pseudomonas + Acinetobacter	1 (4.8)	0 (0.0)
Pseudomonas + Klebsiella	0 (0.0)	2 (5.6)
Acinetobacter + Klebsiella	0 (0.0)	1 (2.8)
Acinetobacter + coagulase (-) Staph. aureus	0 (0.0)	1 (2.8)

¹Represents the total number of attacks occurred among the 12 patients who developed repeated episodes of infections. MRSA: Methicillin-resistant Staphylococcus aureus.